Veltip 2 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Veltip 2 mg Injection

Veltip 2 mg Injection

Veltip 2 mg Injection contains bortezomib, a proteasome inhibitor used in the treatment of certain blood cancers. It is primarily used in treatment regimens for multiple myeloma and mantle cell lymphoma. The injection is administered by a qualified healthcare professional under specialist supervision.

BUY NOW

Category

Veltip 2 mg Injection is a bortezomib-based anticancer medicine supplied for parenteral administration. Bortezomib blocks proteasomes, which can disrupt protein processing and promote the death of abnormal plasma or lymphoma cells. It may be administered by intravenous or subcutaneous injection according to the prescribed treatment protocol. The dose and treatment schedule are individualized based on the patient’s condition, response, and overall treatment regimen.

Technical Specification

Specification Details
Active Ingredient Bortezomib 2 mg
Dosage Form Lyophilized Powder for Injection
Therapeutic Class Proteasome Inhibitor
Main Indication Multiple Myeloma
Route of Administration Intravenous or Subcutaneous
Strength 2 mg

Product Also Known As

Veltip 2 mg Injection, Veltip 2 mg Vial, Veltip Bortezomib 2 mg Injection, Bortezomib 2 mg Injection, Bortezomib Oncology Injection, Bortezomib Proteasome Inhibitor Injection